Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 56.68

-2.4%

Dec 12 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: zeta1961 who wrote (13576)	10/28/2004 2:11:02 PM
From: Ian@SI	of 52153

Another Resveratrol story for Peter... Abstract: Public Release: 28-Oct-2004 American Journal of Physiology-Lung Cellular and Molecular Physiology Red wine mist? Resveratrol shows potential effects against COPD, asthma, arthritis Resveratrol exhibited anti-inflammatory activity in all systems examined: laboratory cells lines as well as human airway epithelial cells. Imperial College London study is novel as it examines the anti-inflammatory mechanism(s) of resveratrol in cells relevant to human disease and explores all proposed mechanisms of action. Resveratrol didn't act as either an estrogen or glucocorticosteroid, both of which hinder patient compliance. Developing an aerosol version seen as key for COPD, steroid-resistant asthma. Pharmascience Inc., Pharmacia (Pfizer), British Lung Foundation, National Asthma Campaign Whole story: eurekalert.org

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next